Literature DB >> 7629771

Acrokeratosis paraneoplastica of Bazex in association with a metastatic neuroendocrine tumour.

S M Halpern1, L J O'Donnell, C N Makunura.   

Abstract

Bazex syndrome is a rare cutaneous paraneoplastic phenomenon not previously reported in association with neuroendocrine tumours. We describe a patient who responded well to treatment with octreotide.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7629771      PMCID： PMC1295246     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


  6 in total

Review 1.  Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases.

Authors:  L J O'Donnell; M J Farthing
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

Review 2.  Somatostatin and a long-acting analogue, octreotide acetate. Relevance to dermatology.

Authors:  C Camisa
Journal:  Arch Dermatol       Date:  1989-03

3.  Acrokeratosis paraneoplastica (Basex) in a patient with bronchial carcinoid tumor.

Authors:  S Brenner; M Brayer; M Topilsky
Journal:  J Am Acad Dermatol       Date:  1987-09       Impact factor: 11.527

Review 4.  Bazex syndrome (acrokeratosis paraneoplastica). An analytic review.

Authors:  J L Bolognia; Y P Brewer; D L Cooper
Journal:  Medicine (Baltimore)       Date:  1991-07       Impact factor: 1.889

Review 5.  Acrokeratosis paraneoplastica--a new cutaneous marker of malignancy.

Authors:  A Bazex; A Griffiths
Journal:  Br J Dermatol       Date:  1980-09       Impact factor: 9.302

6.  Acrokeratosis paraneoplastica of Bazex.

Authors:  S E Handfield-Jones; C N Matthews; J P Ellis; K B Das; D H McGibbon
Journal:  J R Soc Med       Date:  1992-09       Impact factor: 18.000
  6 in total
  1 in total

Review 1.  A Review of Nail Changes in Acrokeratosis Paraneoplastica (Bazex Syndrome).

Authors:  Bipasha Roy; Shari R Lipner
Journal:  Skin Appendage Disord       Date:  2021-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.